• 1
    Leung DYM, Bieber T. Atopic dermatitis. Lancet 2003;361:151160.
  • 2
    Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004;113:651657.
  • 3
    Elias PM, Wood LC, Feingold KR. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermatol 1999;10:119126.
  • 4
    Caubet C, Jonca N, Brattsand M, Guerrin M, Bernard D, Schmidt R et al. Degradation of corneodesmosome protein by two serine proteases of the Kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 2004;122:12351244.
  • 5
    Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, Duff GW et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006;118:321.
  • 6
    Thomas WR, Smith WA, Hales BJ, Mills KL, O'Brien RM. Characterization and immunobiology of house dust mite allergens. Int Arch Allergy Immunol 2002;129:118.
  • 7
    Gough L, Schulz O, Sewell HF, Shakib F. The cysteine protease activity of the major dust mite allergen Der p 1 selectively enhance the immunoglobulin E antibody response. J Exp Med 1999;190:18971902.
  • 8
    Comoy EE, Pestel J, Duez C, Stewart GA, Vendeville C, Fourier C et al. The house dust mite allergen, Dematophagoides pteronyssinus promotes type 2 responses by modulating the balance between IL-4 and IFN-γ. J Immunol 1998;160:24562462.
  • 9
    Jarnik M, Simon MN, Steven AC. Cornified cell envelope assembly: a model based on electronic microscopic determinations of thickness and projected density. J Cell Sci 1998;111:10511060.
  • 10
    Kato T, Takai T, Mitsuishi K, Okumura K, Ogawa H. Cystatin A inhibits IL-8 production by keratinocytes stimulated with Der p 1 and Der f 1: biochemical skin barrier against mite cysteine proteases. J Allergy Clin Immunol 2005;116:169176.
  • 11
    Miedzobrodzki J, Kaszycki P, Bialecka A, Kasprowicz A. Proteolytic activity of Staphylococcus aureus strains isolated from the colonized skin of patients with acute-phase atopic dermatitis. Eur J Clin Microbiol Infect Dis 2002;21:269276.
  • 12
    Lee YA, Wahn U, Kehrt R, Tarani L, Businco L, Gustafsson D et al. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet 2000;26:470473.
  • 13
    Kurz T, Altmueller J, Strauch K, Ruschendorf F, Heinzmann A, Moffatt MF et al. A genome-wide screen on the genetics of atopy in a multiethnic European population reveals a major atopy locus on chromosome‘3q21.3. Allergy 2005;60:192199.
  • 14
    Samuelsson L, Stiller C, Friberg C, Nilsson C, Inerot A, Wahlström J. Association analysis of cystatin A and zinc finger protein 148, two genes located at the psoriasis susceptibility locus PSORS5. J Invest Dermatol 2004;122:13991400.
  • 15
    Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980;92:4447.
  • 16
    Williams HC, Burney PG, Pembroke AC, Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis.III. Independent hospital validation. Br J Dermatol 1994;131:406416.